Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II (PD49)1 Sep 2021PD49-08 CORRELATING IMMUNE CELL INFILTRATION PATTERNS WITH RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA Nicholas Chakiryan, Ali Hajiran, Youngchul Kim, Jad Chahoud, Philippe Spiess, Liang Wang, Carlos Moran-Segura, Jonathan Nguyen, Jasreman Dhillon, James Mule, and Brandon Manley Nicholas ChakiryanNicholas Chakiryan More articles by this author , Ali HajiranAli Hajiran More articles by this author , Youngchul KimYoungchul Kim More articles by this author , Jad ChahoudJad Chahoud More articles by this author , Philippe SpiessPhilippe Spiess More articles by this author , Liang WangLiang Wang More articles by this author , Carlos Moran-SeguraCarlos Moran-Segura More articles by this author , Jonathan NguyenJonathan Nguyen More articles by this author , Jasreman DhillonJasreman Dhillon More articles by this author , James MuleJames Mule More articles by this author , and Brandon ManleyBrandon Manley More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002071.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) tumors harbor comparatively low frequencies of genetic alterations yet very high levels of immune cell infiltration. Identifying associations between specific ccRCC somatic mutations and patterns of immune cell infiltration within the tumor immune microenvironment could be impactful in both research and clinical settings. METHODS: Pre-treatment tumor specimens were collected from 48 patients with metastatic ccRCC. Next-generation sequencing was performed using a 275-gene comprehensive cancer panel. Formalin-fixed paraffin-embedded tissue samples were then stained using 2 multiplex immunofluorescence (IF) panels to identify T cells (CD3, CD8, FOXP3, TBet) and myeloid cells (CD68, CD163, CD206). Using digital image analysis, immune cell marker densities were analyzed in 3 regions of interest (ROIs): the tumor core, the tumor-stroma interface, and the surrounding stroma. Using TCGA, CPTAC, and Moffitt TCC genomic data sources, enrichment scores for individual cell lines were determined from the sequencing panels using the xCell bioinformatic pipeline and compared with IF infiltration patterns. A linear mixed model analysis was performed to test associations between IF patterns and genetic alterations. Log-rank and multivariable Cox regression were used to analyze survival outcomes. RESULTS: Tissue from 24 primary tumors and 24 metastatic tumors were analyzed. The most frequent somatic mutations included VHL (79.1%), BAP1 (41.7%), SETD2 (41.7%), PBRM1 (35.4%), TP53 (18.8%), and KDM5C (16.7%). Overall, tumors with SETD2 mutations had significantly decreased levels of FOXP3+ T regulatory cells across all 3 ROIs. PBMR1 mutations were associated with decreased tumor core FOXP3+ T regulatory cells. KDM5C mutations were associated with significantly increased macrophage tumor infiltration (CD206+ and CD68+/206+). BAP1 mutated tumors had increased sequencing-derived macrophage enrichment scores in TCGA and CPTAC, and AVATAR, but without an associated increase in IF-detected macrophage infiltration in primary tumor samples for any ROI. On multivariable analysis, patients with SETD2 mutations had significantly worse overall survival (p <0.01) and survival following immunotherapy treatment (p <0.01). Patients with KDM5C had worse overall survival (p=0.02) and survival following immunotherapy (p=0.048). CONCLUSIONS: This study provides evidence that there are associations between somatic mutations, such as SETD2 and KDM5C, and macrophage and T cell infiltration patterns in the TIME in ccRCC. Sequencing-derived xCell enrichment scores from TCGA, CPTAC, and AVATAR were discordant with the IF-derived immune cell infiltration findings. These novel associations have the potential to inform precision research and immunotherapeutic treatment strategies. Source of Funding: N/A © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e847-e848 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nicholas Chakiryan More articles by this author Ali Hajiran More articles by this author Youngchul Kim More articles by this author Jad Chahoud More articles by this author Philippe Spiess More articles by this author Liang Wang More articles by this author Carlos Moran-Segura More articles by this author Jonathan Nguyen More articles by this author Jasreman Dhillon More articles by this author James Mule More articles by this author Brandon Manley More articles by this author Expand All Advertisement Loading ...

BRIDGE AS WELL AS A NATURAL BARRIER: CLINICAL SIGNIFICANCE OF RENAL CAPSULAR INVOLVEMENT STATUS IN RENAL CELL CARCINOMA

DYNAMIC CHANGES OF STROMAL CELL IN THE PROCESS OF ESTROGEN/ANDROGEN INDUCED PROSTATIC STROMAL HYPERPLASIA IN CASTRATED RATS

MP27-04 HOMOGENOUS OR HETEROGENOUS BIOLOGICAL BEHAVIORS BETWEEN URETERAL AND RENAL PELVIC TUMORS? A COMPARISON OF CLINICAL FEATURES, PATHOLOGICAL OUTCOMES, EPIGENETIC BIOMARKERS AND ONCOLOGIC PROGNOSIS

PD49-08 CORRELATING IMMUNE CELL INFILTRATION PATTERNS WITH RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA

URINARY FIBRONECTIN AS A PREDICTOR FOR THE PRESENCE OF RESIDUAL TUMOR LOAD AFTER TRANSURETHRAL RESECTION OF BLADDER TRANSITIONAL CELL CARCINOMA

Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Letter.

Carbonic anhydrase IX (CAIX) expression and VHL gene alteration as predictors of survival in renal cell carcinoma

118 EZH2 IS OVEREXPRESSED AND CONTRIBUTES TO APOPTOTIC-RESISTANCE AND METASTASIS IN RENAL CELL CARCINOMA

701 ASSOCIATION OF DYSLIPIDEMIA WITH RENAL CELL CARCINOMA A 12 MATCHED CASE-CONTROL STUDY

MP57-06 BLAND THROMBUS AS AN INDEPENDENT RISK FACTOR FOR SURVIVAL IMPLICATIONS IN RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS

ASSOCIATION OF EGFR FAMILY POLYMORPHISMS AND BLADDER CANCER RISK

983: Bladder Cancer Predisposition: A Pathway-Based Approach to DNA Repair and Cell Cycle Control Genes

MP10-05 MULTIGENE ASSAYS TO PREDICT MALIGNANCY AND DRUG EFFICACY IN RENAL CELL CARCINOMA AND PAN-CANCER: DEVELOPMENT AND DUAL EXTERNAL VALIDATION

The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. Letter.

Subcapsular Collection of Glomerular Filtrate: Rare Form of Page Kidney

MP19-19 INFLUENCING FACTORS OF POSTOPERATIVE RENAL FUNCTION IN RENAL CELL CARCINOMA WITH TUMOR THROMBUS: A LARGE CHINESE CENTER EXPERIENCE

EARLY AND NONINVASIVE DIAGNOSIS OF RENAL CELL CARCINOMA USING 1 H-NMR-BASED METABONOMICS

56: Management of Multilocular Cystic Renal Cell Carcinoma: A Study of 31 Cases

MP08-11 RENAL VEIN OSTIUM WALL INVASION OF RENAL CELL CARCINOMA WITH AN INFERIOR VENA CAVA TUMOR THROMBUS: COMPREHENSIVE MOLECULAR CHARACTERIZATION AND ITS IMPLICATIONS FOR CLINICAL PRACTICE

PD16-07 MOLECULAR MECHANISMS OF CLDN10-ATP5O REGULATION OF MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION TO INHIBIT RENAL CELL CARCINOMA METASTASIS

MP41-19 ASSESSING ADC TARGETS EXPRESSION AND PREDICTIVE CLINICAL INDICATORS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER